Search

everythinglearnresearchcommunity

for

Search:↓

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Scientists found key proteins and genes that affect skin and hair health, and identified potential new treatments for hair loss, skin disorders, and wound healing.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

The study found that a specific signaling pathway helps skin wounds heal faster but may lead to larger scars.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Certain cancer drugs can cause skin issues like rashes and itching.

A rare EGFR mutation in newborns leads to severe health issues and early death.

EGFR inhibitors for lung cancer can cause severe skin issues.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

Lack of KSR1 stops certain skin tumors in mice.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.

Erlotinib can cause hair loss as a side effect.

EREG therapy may help treat hair loss by promoting hair growth.

ZD1839 can cause skin issues like acne and hair changes.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.